✦ LIBER ✦

The design of clinical trials for treatment of diabetic neuropathy

✍ Scribed by Dan Ziegler

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 733 KB
Volume: 21
Category: Article
ISSN: 0893-6609
DOI: 10.1002/(sici)1520-6769(199707)21:1<83::aid-nrc211>3.0.co;2-n

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trial of ganglioside therapy for diabeti

Trial of ganglioside therapy for diabetic neuropathy

✍ Dr. Mark Hallet; Dr. Thomas Flood; Norma Slater; James Dambrosia 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB

Strategy for design of clinical trials o

Strategy for design of clinical trials of chemopreventive agents

✍ Stimson P. Schantz; Waun Ki Hong; Charles W. Boone; Gary J. Kelioff 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

Radiolabelling of NNC 05-1869, a compoun

Radiolabelling of NNC 05-1869, a compound for treatment of diabetic neuropathy

✍ Jacob S. Valsborg; Christian Foged 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 104 KB

## Abstract Synthesis of ^3^H‐, ^14^C‐ and ^125^I‐labelled NNC 05‐1869 is described. The ^3^H‐label was obtained by catalytic hydrogenation of a carbon–carbon double bond with tritium gas, which after purification yielded 470 µCi [^3^H]NNC 05‐1869 with a specific radioactivity of 36 Ci/mmol. ^14^C‐

The use of electrophysiology for the ass

The use of electrophysiology for the assessment of diabetic neuropathy

✍ Joseph C. Arezzo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 733 KB

Expanded clinical trials of treatments f

Expanded clinical trials of treatments for multiple sclerosis

✍ Dr. John N. Whitaker 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB 👁 3 views

Comparison of mania patients suitable fo

Comparison of mania patients suitable for treatment trials versus clinical treatment

✍ Alessandra Talamo; Ross J. Baldessarini; Franca Centorrino 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 1 views

## Abstract It remains uncertain whether bipolar disorder (BPD) patients in randomized‐controlled trials (RCTs) are sufficiently representative of clinically encountered patients as to guide clinical‐therapeutic practice. We complied inclusion/exclusion criteria by frequency from reports of 21 RCTs